425 related articles for article (PubMed ID: 18678792)
1. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
[TBL] [Abstract][Full Text] [Related]
2. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
[TBL] [Abstract][Full Text] [Related]
3. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Perlis RH; Uher R; Perroud N; Fava M
J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
[TBL] [Abstract][Full Text] [Related]
4. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
5. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
[TBL] [Abstract][Full Text] [Related]
6. What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
Rush AJ; South C; Jha MK; Jain SB; Trivedi MH
J Clin Psychiatry; 2020 Aug; 81(5):. PubMed ID: 32780949
[TBL] [Abstract][Full Text] [Related]
7. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
8. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
[TBL] [Abstract][Full Text] [Related]
9. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
[TBL] [Abstract][Full Text] [Related]
10. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
[TBL] [Abstract][Full Text] [Related]
11. Medication augmentation after the failure of SSRIs for depression.
Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
[TBL] [Abstract][Full Text] [Related]
12. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
Davis LL; Rush JA; Wisniewski SR; Rice K; Cassano P; Jewell ME; Biggs MM; Shores-Wilson K; Balasubramani GK; Husain MM; Quitkin FM; McGrath PJ
Compr Psychiatry; 2005; 46(2):81-9. PubMed ID: 15723023
[TBL] [Abstract][Full Text] [Related]
13. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
Trials; 2011 Jan; 12():4. PubMed ID: 21208417
[TBL] [Abstract][Full Text] [Related]
14. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
[TBL] [Abstract][Full Text] [Related]
15. Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Trivedi MH; Morris DW; Wisniewski SR; Lesser I; Nierenberg AA; Daly E; Kurian BT; Gaynes BN; Balasubramani GK; Rush AJ
Am J Psychiatry; 2013 Jun; 170(6):633-41. PubMed ID: 23558394
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
[TBL] [Abstract][Full Text] [Related]
17. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
18. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Leelahanaj T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
[TBL] [Abstract][Full Text] [Related]
19. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
[TBL] [Abstract][Full Text] [Related]
20. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
